Investigators posit that wearable devices will help psychiatrists to target mood and cognitive interventions.
Higher cardiovascular risk burden assessed by the Framingham General Cardiovascular Risk Score is associated with cognitive decline and structural brain differences.
Researchers explored the association between midlife serum uric acid and the risk for cognitive decline and dementia.
Black individuals’ higher cumulative BP levels may contribute to racial differences in cognitive decline.
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
Closer adherence to the aMED is associated with a reduced risk for cognitive decline, but not with slower decline in cognitive function.
Between the aspirin and placebo groups, there was no significant difference in the risk for all dementia triggers, probable Alzheimer disease, or mild cognitive impairment.
Rate of cognitive decline was even faster among widowed participants with higher β-amyloid levels at baseline.
A simple SVD score using MRI scans, may aid in identifying patients with SVD who are likely to develop cognitive decline.
The USPSTF states the balance of benefits and harms of cognitive impairment screening for older adults cannot be established due to lack of evidence.